Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04006483 · ClinicalTrials.gov registry record

Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque

A clinical trial of Dental Plaque, sponsored by Procter and Gamble.

Completed
Registry status
2,359
Enrollment target
1
Study location

NCT04006483 is a study of Dental Plaque that has completed, run by Procter and Gamble. The registered enrollment target is 2,359 participants, above the 389-participant average among 10 other Dental Plaque trials with a reported enrollment target (506% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04006483, a study of Dental Plaque, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
2,359 participants
Enrollment target
1
Study location

Study Summary

The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.

Conditions Studied

Interventions

  • DRUG Stannous fluoride dentifrice
  • DRUG Positive control dentifrice
  • DRUG Negative control dentifrice

Study Locations (1)

Ohio

  • Multiple P&G Investigation Clinical Sites - Cincinnati

Trial Details

FieldValue
Enrollment Target 2,359 participants
Start Date 2018-01-08
Est. Completion 2018-11-30

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT04006483

The ClinicalTrials.gov registry entry for NCT04006483 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,359 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 389-participant average among 10 other Dental Plaque trials with a reported enrollment target (506% higher). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 3 interventions - of which Stannous fluoride dentifrice is the first listed.

NCT04006483 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04006483 about?

NCT04006483 is a clinical study titled "Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque". The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.

What is the current status of trial NCT04006483?

This trial is currently completed. The enrollment target is 2,359 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.

What conditions does trial NCT04006483 study?

This clinical trial studies the following conditions: Dental Plaque.

What interventions are being tested in trial NCT04006483?

The interventions under investigation include: Stannous fluoride dentifrice (DRUG), Positive control dentifrice (DRUG), Negative control dentifrice (DRUG).

Who is sponsoring clinical trial NCT04006483?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04006483 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Plaque

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.